Connect
MJA
MJA

The switch to new conjugated vaccines may compromise immunisation coverage for refugees

Christine B Phillips and Mahomed Patel
Med J Aust 2006; 184 (9): . || doi: 10.5694/j.1326-5377.2006.tb00324.x
Published online: 1 May 2006

To the Editor: On 1 November 2005, the Australian states and territories introduced quadrivalent, pentavalent or hexavalent vaccines for childhood immunisations. This simplifies vaccination for young children, but may impair the ability of health services to provide primary immunisation for refugees over the age of 8 years.


  • Australian National University, Canberra, ACT.



  • 1. World Health Organization, UNICEF, World Bank. State of the world’s vaccines and immunization. New York: UNICEF, 2002.
  • 2. Australian Government Department of Immigration, Multicultural and Indigenous Affairs. Fact sheet 60. Australia’s refugee and humanitarian program. Available at: http://www.immi.gov.au/facts/60refugee.htm (accessed Oct 2005).
  • 3. Australian Government Department of Health and Ageing. The Australian immunisation handbook. 8th ed. Canberra: AGPS, 2003.
  • 4. GlaxoSmithKline. Boostrix: prescribing information. Available at: http://us.gsk.com/products/assets/us_boostrix.pdf (accessed Jan 2006).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.